To include your compound in the COVID-19 Resource Center, submit it here.

RXi raises $12 million

RXi Pharmaceuticals Corp. (NASDAQ:RXII) raised $12 million through the sale

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE